Serving the Society Since 1986
Advanced Search
Volume 05 Issue 4
August 1990
    Citation: AO Wen-Ban, HUANG Pu-Chang, WANG Xing-Bo, Tun-Tao-Lin, ZHOU Ke-Cha, ZHANG Xiu-Hui, ZHANG Yuan-Yang, LIN Ke-Yong. Efficacy of Treating Chronic Hepatitis B with HB Vaccine and Small Doses of Interferon and Thymosin .VIROLOGICA SINICA, 1990, 5(4) : 379.
    shu

    Efficacy of Treating Chronic Hepatitis B with HB Vaccine and Small Doses of Interferon and Thymosin

    • 1.

      Lianyungang Health and Anti-epidemic Station

    • 2.

      Lianyungang 222003Lianyungang Canned Food Factory

    • 3.

      Lianyungang 222003

    • Available online: 05 December 1990
    • In this paper chronic hepatitis B and its virus carriers were treated with HB Vaccine and small doses of interferon and thymosin. After one course of interferon group, placenta peptide group and HB-Vaccine group, the negative percentage of HBsAg were 13.7%, 5.9% and 0%, respectively. The changes of HBeAg were 68.8%, 72.7% and 20%, respectively. The results showed that combination of interferon and immunologic stimulant can control the replication of Hepatitis B Virus, and impel HBeAg to change, but can not ...
    • 加载中
    • 加载中
    PDF

    Article Metrics

    Article views(3882) PDF downloads(814) Cited by()

    Related
    Proportional views

      Efficacy of Treating Chronic Hepatitis B with HB Vaccine and Small Doses of Interferon and Thymosin

      • 1. Lianyungang Health and Anti-epidemic Station
      • 2. Lianyungang 222003Lianyungang Canned Food Factory
      • 3. Lianyungang 222003

      Abstract: In this paper chronic hepatitis B and its virus carriers were treated with HB Vaccine and small doses of interferon and thymosin. After one course of interferon group, placenta peptide group and HB-Vaccine group, the negative percentage of HBsAg were 13.7%, 5.9% and 0%, respectively. The changes of HBeAg were 68.8%, 72.7% and 20%, respectively. The results showed that combination of interferon and immunologic stimulant can control the replication of Hepatitis B Virus, and impel HBeAg to change, but can not ...

        HTML

      目录

      This journal is a member of, and subscribes to the principles of, the Committee on Publication Ethics (COPE)

      鄂ICP备05001977号

         

      鄂公网安备 42010602003674号

      Copyright © 2019 Virologica Sinica. All rights reserved

      /

      DownLoad:  Full-Size Img  PowerPoint
      Return
      Return